Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)

dc.creator	Zachou, K.	en
dc.creator	Liaskos, C.	en
dc.creator	Christodoulou, D.	en
dc.creator	Kardasi, M.	en
dc.creator	Papadamou, G.	en
dc.creator	Gatselis, N.	en
dc.creator	Gerovasilis, F.	en
dc.creator	Tsianos, E.	en
dc.creator	Dalekos, G.	en
dc.date.accessioned	2015-11-23T10:54:36Z
dc.date.available	2015-11-23T10:54:36Z
dc.date.issued	2002
dc.identifier	10.1016/s0168-8278(02)80498-6
dc.identifier.issn	0168-8278
dc.identifier.uri	http://hdl.handle.net/11615/34780
dc.source.uri	<Go to ISI>://WOS:000175704700494
dc.subject	Gastroenterology & Hepatology	en
dc.title	Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)	en
dc.type	journalArticle	en

Αρχεία σε αυτό το τεκμήριο

Αρχεία	Μέγεθος	Τύπος	Προβολή
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.